Commercializing Neoantigens: Uniting Neoantigen & Cancer Vaccines to Compete with Other Treatments for Patients
Time: 9:00 am - 12:00 pm
day: Workshop A
Take part in the broader discussion on neoantigens in the context of a broader consideration of where cancer vaccines are headed. Join the
leading discussion on how vaccines can outperform other treatment options and immuno-oncology modalities. Get ahead of the curve and see how far the field has progressed in terms of translating great ideas into clinical reality.
- Factoring preclinical considerations for cancer vaccines in early development for biotechnology companies
- Deep dive into understanding clinical and market context – the value proposition
- Considering clinical development strategies for value inflection